Back to search results

Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.

Abroad (travel likely)RecruitingPHASE3

Conditions

Juvenile Idiopathic Arthritis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Phoenix Children's Hospital /ID# 253403, Phoenix, Arizona, United States

    Study coordinator · sgorry@phoenixchildrens.com · 602-933-3822

  • Arkansas Children'S Hospital /ID# 278405, Little Rock, Arkansas, United States

  • Childrens National Medical Center /ID# 253344, Washington D.C., District of Columbia, United States

  • Joe Dimaggio Children's Hospital Hollywood /ID# 278992, Hollywood, Florida, United States

  • New York Medical College /ID# 253437, Valhalla, New York, United States

    Study coordinator · 914-504-0152

  • Levine Children's Hospital /ID# 253491, Charlotte, North Carolina, United States

  • Cincinnati Childrens Hospital Medical Center /ID# 251827, Cincinnati, Ohio, United States

    Study coordinator · megan.quinlan-waters@cchmc.org · 1-513-636-3644

  • Nationwide Children'S Hospital /ID# 278994, Columbus, Ohio, United States

  • Randall Children's Hospital /ID# 251829, Portland, Oregon, United States

    Study coordinator · bbogle@lhs.org · 1-503-413-3508

  • UT Health Houston /ID# 278665, Houston, Texas, United States

  • Children'S Wisconsin /ID# 278652, Milwaukee, Wisconsin, United States

  • Instituto CAICI S.R.L /ID# 251448, Rosario, Santa Fe Province, Argentina

  • Centro de Investigaciones Medicas Tucuman /ID# 251781, San Miguel de Tucumán, Tucumán Province, Argentina

  • Hospital de Niños de la Santisima Trinidad /ID# 252736, Córdoba, Argentina

    Study coordinator · 351 458-6405

  • Monash Health - Monash Medical Centre - Clayton /ID# 251691, Clayton, Victoria, Australia

  • Royal Children's Hospital /ID# 251663, Parkville, Victoria, Australia

  • Landeskrankenhaus Bregenz /ID# 266317, Bregenz, Vorarlberg, Austria

  • CMiP - Centro Mineiro de Pesquisa Ltda - ME /ID# 251769, Juiz de Fora, Minas Gerais, Brazil

  • Hospital Sao Paulo /ID# 251765, São Paulo, Brazil

  • Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao /ID# 251764, São Paulo, Brazil

  • The Childrens Hospital of Chongqing Medical University /ID# 251539, Chongqing, Chongqing Municipality, China

  • Children'S Hospital Of Soochow University /ID# 251755, Suzhou, Jiangsu, China

  • Xi'an Children's Hospital /ID# 251693, Xi'an, Shaanxi, China

  • Children's Hospital of Fudan University /ID# 251619, Shanghai, Shanghai Municipality, China

  • The Children's Hospital of Zhejiang University School of Medicine /ID# 251754, Hangzhou, Zhejiang, China

  • Universitaetsklinikum Freiburg /ID# 253288, Freiburg im Breisgau, Baden-Wurttemberg, Germany

    Study coordinator · kjk.pedrheum@uniklinik-freiburg.de

  • Asklepios Klinik Sankt Augustin /ID# 251565, Sankt Augustin, North Rhine-Westphalia, Germany

  • St. Josef-Stift Sendenhorst /ID# 268680, Sendenhorst, North Rhine-Westphalia, Germany

  • Hamburger Zentrum fuer Kinder- und Jugendrheumatologie /ID# 251564, Hamburg, Germany

  • Semmelweis Egyetem /ID# 266750, Budapest, Hungary

  • Azienda Ospedaliero Universitaria Meyer /ID# 251775, Florence, Firenze, Italy

  • IRCCS Istituto Giannina Gaslini /ID# 251776, Genoa, Genova, Italy

  • Hyogo Prefectural Kobe Children'S Hospital - Minatojima /ID# 251649, Kobe, Hyōgo, Japan

    Study coordinator · +81-78-945-7300

  • St Marianna University School Of Medicine /ID# 251623, Kawasaki-shi, Kanagawa, Japan

  • Niigata University Medical and Dental Hospital /ID# 251538, Niigata, Niigata, Japan

  • Osaka Medical and Pharmaceutical University Hospital /ID# 252092, Takatsuki-shi, Osaka, Japan

  • Institute of Science Tokyo Hospital /ID# 251505, Bunkyo-ku, Tokyo, Japan

  • CREA de Guadalajara SC /ID# 252917, Guadalajara, Jalisco, Mexico

  • Universitair Medisch Centrum Utrecht /ID# 267435, Utrecht, Netherlands

  • Maria Sklodowska Curie Hospital /ID# 282447, Bucharest, Bucharest, Romania

  • Spitalul Clinic De Urgenta Pentru Copii Louis Turcanu /ID# 279931, Timișoara, Timiș County, Romania

  • Spitalul Clinic De Urgenta Pentru Copii Sf. Maria /ID# 279813, Iași, Romania

  • Cape Peadiatric Rheumatology /ID# 282533, Cape Town, Western Cape, South Africa

  • Hospital Sant Joan de Deu /ID# 251353, Esplugues de Llobregat, Barcelona, Spain

  • Hospital Universitario y Politecnico La Fe /ID# 251352, Valencia, Spain

    Study coordinator · reumainf_lafe@gva.es · +34 961 244 357

  • Ostersunds Sjukhus /ID# 281645, Östersund, Jämtland County, Sweden

  • Skane University Hospital Lund /ID# 282573, Lund, Skåne County, Sweden

  • Akademiska Sjukhuset - Uppsala University Hospital /ID# 282653, Uppsala, Uppsala County, Sweden

  • Queen Silvia Children's Hosp /ID# 251318, Gothenburg, Västra Götaland County, Sweden

    Study coordinator · +46313435865

  • National Taiwan University Hospital /ID# 267387, Taipei, Taiwan

  • Linkou Chang Gung Memorial Hospital /ID# 267390, Taoyuan City, Taiwan

  • Gazi University Medical Faculty /ID# 253677, Ankara, Turkey (Türkiye)

  • Istanbul University Istanbul Medical Faculty /ID# 251652, Istanbul, Turkey (Türkiye)

  • Istanbul Universitesi-Cerrahpasa Cerrahpasa Tip Fakultesi /ID# 251651, Istanbul, Turkey (Türkiye)

  • Umraniye Training and Res Hosp /ID# 251653, Istanbul, Turkey (Türkiye)

  • Great Ormond Street Children's Hospital /ID# 251512, London, Greater London, United Kingdom

Study leads

  • ABBVIE INC.

    Study Director

    AbbVie

View source on ClinicalTrials.gov(opens in a new tab)